Simulations Plus to Present at the Berenberg Discover AI Seminar

Rhea-AI Summary

Simulations Plus, a leader in modeling and simulation software for pharmaceutical safety, announced participation in the Berenberg Discover AI Seminar on April 26, 2022, in Boston, Massachusetts. CEO Shawn O’Connor will hold one-on-one meetings during the event. For details on the seminar, the slide presentation will be accessible on the Simulations Plus Investors page. With 25 years of experience, Simulations Plus supports drug discovery and regulatory submissions through advanced software solutions licensed by major pharmaceutical companies and regulatory agencies worldwide.

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that management will be participating in the Berenberg Discover AI Seminar at The Newbury Boston in Boston, Massachusetts, on April 26, 2022.

Shawn O’Connor, chief executive officer, will be participating in one-on-one meetings throughout the day. For more information about the Berenberg Discover AI Seminar, please visit the conference website or contact Brian Siegel from Hayden IR at brian@haydenir.com. The company’s slide presentation will be available on the Investors page of the Simulations Plus website.

About Simulations Plus

Serving clients worldwide for 25 years, Simulations Plus is a leading provider in the biosimulation market providing software and consulting services supporting drug discovery, development, research, and regulatory submissions. We offer solutions that bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on Twitter | LinkedIn.

Environmental, Social, and Governance (ESG)

We focus our Environmental, Social, and Governance (ESG) efforts where we can have the most positive impact. To learn more about our latest initiatives and priorities, please visit our website to read our ESG Report

View source version on businesswire.com: https://www.businesswire.com/news/home/20220419005473/en/

Simulations Plus Investor Relations

Ms. Renee Bouche

661-723-7723

renee.bouche@simulations-plus.com

Hayden IR

Mr. Brian Siegel

346-396-8696

brian@haydenir.com

Source: Simulations Plus, Inc.

FAQ

What event will Simulations Plus participate in on April 26, 2022?

Simulations Plus will participate in the Berenberg Discover AI Seminar in Boston.

Who is representing Simulations Plus at the Berenberg Discover AI Seminar?

CEO Shawn O’Connor will represent Simulations Plus at the seminar.

Where can I find the slide presentation from Simulations Plus at the seminar?

The slide presentation will be available on the Simulations Plus Investors page.

What services does Simulations Plus offer in the biosimulation market?

Simulations Plus provides software and consulting services for drug discovery, development, and regulatory submissions.

How long has Simulations Plus been operating in the biosimulation market?

Simulations Plus has been serving clients worldwide for 25 years.

What is the ticker symbol for Simulations Plus?

The ticker symbol for Simulations Plus is SLP.